Synergenics - About the company
Synergenics is a funded company based in San Francisco (United States), founded in 2002 by William J Bill Rutter. It operates as a Consortium provides shared resources and support for independent biotech start-ups. Synergenics has raised an undisclosed amount in funding. The company has 869 active competitors, including 59 funded and 50 that have exited. Its top competitors include companies like Alloy Therapeutics, Simulations Plus and Manifold Bio.
Company Details
Consortium provides shared resources and support for independent biotech start-ups. It offers financial support, shared laboratory facilities, and management services to member companies. This structure aims to create economies of scale and foster collaboration among companies, while protecting each company’s proprietary domains.
- Website
- synergenics.net
- Social
- Email ID
- *****@synergenics.net
- Phone Number
- +1 **********
Key Metrics
Founded Year
2002
Location
San Francisco, United States
Stage
Funding Raised
Latest Funding Round
Investors
Ranked
162nd among 869 active competitors
Employee Count
11 as on Aug 31, 2026
Investment & Acquisitions
Similar Companies
Sign up to download Synergenics' company profile
Synergenics's funding and investors
Synergenics has raised funding over 1 round. Its latest funding round was a Grant (prize money) round on May 29, 2009 for $*****. 1 investor participated in its latest round. Synergenics has 1 institutional investor.
Here is the list of recent funding rounds of Synergenics:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
May 29, 2009 | 3339147 | Grant (prize money) | 2845635 | 2734716 | 4782189 | 3125515 |
Access funding benchmarks and valuations. Sign up today!View details of Synergenics's funding rounds and investors
Synergenics' founders and board of directors
Founder? Claim ProfileThe founders of Synergenics is William J Bill Rutter. Sebastian Bernales is the CEO of Synergenics.
Here are the details of Synergenics' key team members:
- William J Bill Rutter: Former Founder of Synergenics.
- Sebastian Bernales: CEO of Synergenics. Contact Info: 1 email address
View details of Synergenics's Founder profiles and Board Members
Synergenics' employee count trend
Synergenics has 11 employees as of Aug 26. Here is Synergenics's employee count trend over the years:
Uncover Synergenics' growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Synergenics's Competitors and alternates
Top competitors of Synergenics include Alloy Therapeutics, Simulations Plus and Manifold Bio. Here is the list of Top 10 competitors of Synergenics, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Alloy Therapeutics 2017, Lexington (United States), Series E | Provider of drug discovery services | $157M | 69/100 | |
2nd |  Simulations Plus 1996, Lancaster (United States), Acquired | Developer of modeling and simulation software and consulting services provider | - | 60/100 | |
3rd |  Manifold Bio 2018, United States, Series A | Developer of tissue-targeted therapeutics using in vivo screening and AI design | $78.2M | 54/100 | |
4th | Service to develop health products aiming to diagnose, prevent, delay the progression or treat hearing loss and tinnitus | $42.3M | 54/100 | ||
5th | Helogen 2024, Mountain View (United States), Seed | Provider of space-based biomanufacturing and drug discovery services | $7.1M | 52/100 | |
6th | Viva Biotech 2006, Shanghai (China), Public | Research services focused on drug discovery and development | - | 51/100 | |
7th |  ArcaScience 2018, Paris (France), Seed | Developer of AI models for patient-centric insights in drug development | $7M | 51/100 | |
8th |  Arctoris 2016, Abingdon (United Kingdom), Seed | Provider of automated wet lab biology research and data generation services | $3.93M | 51/100 | |
9th | Provider of drug discovery and development services | $1.9M | 50/100 | ||
10th |  Superluminal Medicines 2022, Boston (United States), Series B | Generative biological and chemical company focused on drug discovery | $223M | 51/100 | |
162nd |  Synergenics 2002, San Francisco (United States), Funding Raised | Consortium provides shared resources and support for independent biotech start-ups | - | 23/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Synergenics's competitors? Click here to see the top ones
Synergenics's Investments and acquisitions
Synergenics has made 2 investments in Bluejay Therapeutics and Hemogenomics. Synergenics has not made any acquisitions as of now.Reports related to Synergenics
Here is the latest report on Synergenics's sector:
Are you a Founder ?
FAQs about Synergenics
Explore our recently published companies
- Leonardo Global - Rome based, Unfunded company
- UMO Technologie Militarne i Policyjne - Warsaw based, 1997 founded, Unfunded company
- Solembra - France based, 2014 founded, Unfunded company
- Neuron Software - Hungary based, 1998 founded, Unfunded company
- Cybele Health - San Francisco based, 2023 founded, Unfunded company
- Cittrix Roofing - Mundelein based, Unfunded company
